Inotersen improves quality of life and neuropathy in patients with hereditary transthyretin (hATTR) amyloidosis with polyneuropathy: results of the phase 3 study NEURO-TTRT. Coelho,A. Wang,M. Waddington Cruz,M. Polydefkis,P. Dyck, M. Scheinberg, V. Plante-Bordeneuve,J. Berk,F. Barroso,D. Adams,T. Brannagan,C. Whelan,G. Merlini,B. Drachman,S. Heitner,I. Conceicao,H. Schmidt, G. Vita,J. Gamez, E. Gane, P. Gorevic, A. Souza Bulle Oliveira,B. Monia,M. Gertz,M. BensonVALUE IN HEALTH（2018）引用 0|浏览24暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
